Financial Data and Key Metrics Changes - In 2025, the company achieved record revenues of $51 million, representing a 27% year-over-year growth, while net income increased by 57% to a record $3.6 million [1] - The company exited 2025 with a substantial contracted backlog of $24 million, providing good visibility into the upcoming year [1][8] - Cash and equivalents grew to $11.8 million, up from $3.6 million at year-end 2024, and shareholders' equity increased to almost $29 million from $21 million [6][7] Business Line Data and Key Metrics Changes - The RFID Division faced challenges due to ongoing geopolitical tensions in Israel, leading to goodwill impairment charges of $1.2 million in 2025 [3] - The company plans to enter the hospital segment in 2026 to reduce exposure to the sensitive Israeli civilian market, with expected revenue contributions starting in 2027 [4][3] Market Data and Key Metrics Changes - The defense sector remains robust, driving growth in the supply chain and Robotics Division, with strong backlog visibility and healthy customer relationships [2] - The company appointed an Indian representative to expand its geographic reach, capitalizing on India's growth as a subcontracting hub for global defense programs [2] Company Strategy and Development Direction - The company aims to broaden its portfolio of manufacturers and embrace new technologies to support organic growth [2] - A strategic focus on the hospital segment is intended to stabilize and grow the RFID business, requiring investment in personnel and product offerings [3][4] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the defense segment's growth potential, while acknowledging the negative impact of geopolitical tensions on the RFID Division [12] - The company projects revenues of approximately $51 million and net income of around $3.6 million for 2026, maintaining a conservative outlook due to the sensitive geopolitical environment [8][15] Other Important Information - The USD to Israeli shekel exchange rate devalued by approximately 13% at the start of 2026, leading to increased operating expenses [5] - The company plans to shift its investor relations strategy towards digital marketing to enhance market awareness and visibility [9][10] Q&A Session Summary Question: Impact of ongoing war on business - Management indicated that the defense segment would likely benefit from prolonged conflict, while the RFID Division would be negatively impacted [12][13] Question: Guidance for 2026 revenue and net income - Management clarified that the guidance reflects a conservative approach, with expectations of continued growth potential despite geopolitical tensions [14][15][16] Question: M&A strategy and cash utilization - The company is evaluating several acquisition opportunities and plans to invest cash in securities until suitable M&A opportunities arise [17][18][20] Question: Revenue from India and customer relationships - Management confirmed that revenue from India averaged around $3 million over the past three years, with expectations for significant growth [22][53] Question: Investment in the hospital market - Initial investment in the hospital segment is expected to be around $200,000, with profitability anticipated by 2028 [27][29] Question: Tax implications for 2026 - Management expects to utilize tax loss carryforwards, resulting in no significant tax expenses for 2026 [41][42]

Financial Data and Key Metrics Changes - In 2025, the company achieved a 9% revenue growth compared to 2024, with total revenue of $16 million in Q4, representing a 4% decline year-over-year primarily due to lower system sales [9][18] - Recurring revenue increased by 15% over 2024, reaching $46.3 million for the full year, with Q4 recurring revenue growing 17% to $12.7 million [20][21] - Gross margin for Q4 was 43%, slightly up from 42% in Q4 2024, while the full year gross margin was 46%, down from 48% in 2024 due to inflationary costs and tariffs [22][23] Business Line Data and Key Metrics Changes - The installed base of ALLY systems grew by nearly 50% compared to year-end 2024, reaching approximately 200 systems, with procedure volume increasing by over 20% year-over-year for both Q4 and the full year [8][21] - The company placed 15 ALLY systems in Q4, contributing to a total of 206,000 procedures globally for the year, with a significant increase in market share from 14% to 23.4% in the U.S. [10][21] Market Data and Key Metrics Changes - The company faced challenges in international markets due to uncertainty surrounding the acquisition, leading to only one ALLY system sale outside the U.S. in Q4 2025, compared to 10 in Q4 2024 [18][19] - The company anticipates a gradual return to significant system growth in international markets as distributors re-engage following the termination of the merger [14][19] Company Strategy and Development Direction - The company aims to focus on growing procedure volumes and recurring revenue through additional system placements and increased utilization of existing systems [15][24] - The strategy includes maintaining cost discipline and enhancing cash flow, particularly as international sales ramp up [24][25] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about returning to historical operating performance, with expectations for gradual growth in 2026 following a challenging 2025 [9][24] - The termination of the merger is viewed as an opportunity to refocus and capitalize on market opportunities, with management confident in the company's ability to drive long-term success [59][60] Other Important Information - The company received a $10 million transaction deposit following the termination of the merger, which will enhance its cash position [8][17] - The company recorded $17.1 million in total acquisition costs in 2025, with a portion of these costs expected to be eliminated due to the merger's termination [17][23] Q&A Session Summary Question: Distributor commentary and growth re-acceleration - Management acknowledged positive conversations with distributors but cautioned that it may take several quarters to regain momentum in international markets [28][30] Question: U.S. procedure growth and recurring revenue - Management indicated that U.S. procedure growth remains strong, with expectations for continued performance from the installed base of systems [39][40] Question: Operating expenses and future projections - Management confirmed a 10% increase in cash-based operating expenses for 2026, with expectations for further increases in 2027 as operations stabilize [35][45] Question: Opportunities in international markets - Management highlighted potential growth in markets like Australia and New Zealand, as well as a return to activity in Southeast Asia and Europe [46][48]

Financial Data and Key Metrics Changes - The company reported total revenue of $16 million for Q4 2025, representing a 4% decline year-over-year, primarily due to lower system sales [18] - Full year 2025 revenue increased by 9% compared to 2024, with recurring revenue growing by 15% [20][21] - The gross margin for Q4 was 43%, slightly up from 42% in Q4 2024, while the full year gross margin was 46%, down from 48% in 2024 [22][23] Business Line Data and Key Metrics Changes - The installed base of ALLY systems grew to approximately 200, with a 48% year-over-year increase, and procedure volume increased by 20% year-over-year [22] - The company achieved a 23.4% procedure share in the U.S. by the end of 2025, up from 14% [10] - The company placed 15 ALLY systems in Q4 2025, contributing to a total of 206,000 procedures globally for the year [22] Market Data and Key Metrics Changes - U.S. ALLY sales increased by one system to 12 in Q4 2025, while international sales dropped significantly from 10 systems in Q4 2024 to just one in Q4 2025 [18][19] - The company noted that the uncertainty surrounding the acquisition negatively impacted international business expansion [13] Company Strategy and Development Direction - The company aims to focus on growing procedure volumes and recurring revenue through additional system placements and increased utilization of existing systems [15] - The strategy includes re-engaging with distributors and stakeholders to regain momentum lost during the acquisition process [14] - The company plans to explore new markets, including Australia and New Zealand, and expand its presence in Europe and Southeast Asia [50][55] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about returning to historical operating performance and emphasized the importance of rebuilding momentum over the next several quarters [9][61] - The company acknowledged the challenges faced during the acquisition process but highlighted the validation of its technology and market position [5][6] - Management expects to see gradual improvements in system sales and recurring revenue as distributors re-engage [20][42] Other Important Information - The company received a $10 million transaction deposit following the termination of the acquisition, which will enhance its cash position [8][17] - The company recorded $17.1 million in total acquisition costs in 2025, with a portion expected to be eliminated due to the termination of the merger [17] Q&A Session Summary Question: Can you elaborate on the distributor commentary and its impact on growth? - Management indicated that while conversations with distributors have been positive, it will take time to regain momentum in international markets due to previous uncertainties [29][32] Question: How should we think about the mix of capital placements versus lease-based placements? - Management noted that revenue recognition differs between U.S. and international sales, with a potential shift towards more lease-based placements in the U.S. [33][36] Question: Can you clarify the expected increase in operating expenses for 2026? - Management confirmed that cash-based operating expenses are expected to increase by 10%, excluding merger-related costs [37][38] Question: What is the outlook for U.S. procedure growth given recent trends? - Management reported that recurring revenue is becoming healthy, with expectations for continued growth in procedure volumes driven by the installed base [41][42] Question: Are there new market opportunities outside the U.S.? - Management expressed interest in exploring markets like Australia and New Zealand, as well as expanding in Europe and Southeast Asia [50][55]

Financial Data and Key Metrics Changes - For the year ended December 31, 2025, the company reported total revenue of approximately $54 million, an 18% decline from approximately $66 million in 2024, primarily due to lower contributions from healthcare operations [18] - Full year healthcare operations revenue was approximately $40 million compared to approximately $52 million in 2024, with Q4 revenues of approximately $9 million being relatively stable compared to $10 million in Q3 [19] - Consolidated gross margin for the full year was approximately 20%, down from approximately 26% in 2024, but with sequential improvement expected throughout 2026 [22] Business Line Data and Key Metrics Changes - The healthcare segment represented about 73% of total revenue in 2025, with a significant focus on higher margin 340B covered entities and medication fulfillment services [5][10] - The e-commerce segment saw revenue increase to approximately $15 million, up 6% year-over-year, driven by strong demand for satellite connectivity and IoT products [20] Market Data and Key Metrics Changes - The company reported a 94% increase in 340B contract revenue for Q4 2025 compared to Q3 2025, indicating strong growth in this area [9] - The expansion of healthcare operations from Florida to nationwide through a partnership with HealthWarehouse is expected to drive significant growth opportunities [10][16] Company Strategy and Development Direction - The company is focused on transitioning towards higher margin, recurring revenue streams, particularly in healthcare services, which is expected to improve margins and predictability over time [19] - The strategic refocusing and cost optimization initiatives have led to a reduction in operating expenses by approximately 25% to $20 million [22] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about early signs of margin improvement and a reduction in operating losses by the latter half of 2026 [8][26] - The company aims to leverage its partnership with HealthWarehouse to expand its healthcare offerings nationally and support multi-state contracted customers [26][27] Other Important Information - The company completed a reverse stock split to maintain its Nasdaq listing, which management believes was necessary despite investor negativity [3][4] - The company ended the year with nearly $14 million in cash and no meaningful debt, providing flexibility for operations and growth investments [23] Q&A Session All Questions and Answers Question: Was the reverse split necessary? - Management indicated that maintaining the Nasdaq listing was critical for growth and expansion plans, making the reverse split the most viable option at this time [27][28] Question: What are the current plans for the buyback? - Reinstating the buyback program is under consideration, with details to be announced when appropriate [28] Question: Can you comment on the status of ongoing lawsuits? - The company is working with counsel to resolve remaining legal matters while protecting shareholder interests, with options including proceeding to trial or reaching a settlement [29][30]

Financial Data and Key Metrics Changes - For Q4 2025, revenue was $12.5 million, roughly even compared to the previous year, with gross profit of $3.4 million and a gross margin of 27%, up from 22% in Q4 2024 [4][5] - Full year 2025 revenue reached a record $62.1 million, up 18.6% from $51.9 million in 2024, while full year gross profit was $16.1 million, slightly down from $16.2 million in 2024 [5][6] - Adjusted EBITDA for 2025 was $4.2 million, less than 7% of revenue, with a target of returning to double-digit EBITDA in 2026 [6][7] Business Line Data and Key Metrics Changes - The company launched 20 new brand partners in 2025, contributing to substantial revenue growth [5] - Transition costs and operational inefficiencies from facility consolidation impacted margins, with labor costs and inventory control being significant challenges [6][10] Market Data and Key Metrics Changes - The company anticipates a normalization of revenue in 2026, with a current shift in open orders at just under $33 million compared to $38 million a year ago [8][17] - The global beauty and personal care market is valued at over $500 billion, with SPF-infused beauty products positioned as a central aspect of consumer spending [16] Company Strategy and Development Direction - The "Transform and Transcend" initiative aims to enhance operational health and achieve a gross margin floor of 30% in 2026, focusing on eliminating inefficiencies and improving production flow [7][11] - The initiative includes four pillars: operational excellence, technology-driven expansion, a new product development model, and collaborative globalization [12][14] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in achieving full year guidance for 2026 despite anticipated revenue normalization, emphasizing the importance of execution and operational improvements [8][17] - The company aims to stabilize its foundation in 2026 to set the stage for the most profitable years in its history [41] Other Important Information - The company increased its patent portfolio by 20%, now totaling over 120 patents, which strengthens its market position [9] - New leadership appointments, including a seasoned CFO, are part of the strategy to achieve profitable growth [15] Q&A Session Summary Question: Will EPS in 2026 be at or above the 2024 levels? - Management is not prepared to provide EPS guidance at this time but expects an increase in EBITDA to return to double digits in 2026 [19][20] Question: Can you address the aspirational roadmap to grow the company to $200 million? - Management highlighted the importance of addressing operational execution challenges and leveraging innovation to capture market growth [24][26] Question: Why have there been struggles with production? - Management noted simultaneous growth and the installation of new capabilities as challenges, but expressed confidence in future performance [34][35] Question: Did the company lose a brand partner? - Management clarified that there was no loss of a brand partner, but acknowledged challenges with sell-through from one of their large customers [35][36] Question: Why did it take so long to schedule this call? - The scheduling was dependent on the completion of the year-end audit, which is planned almost a year in advance [36]

Financial Data and Key Metrics Changes - TOYO reported record-breaking revenue of over $427 million for fiscal year 2025, a 142% increase from 2024, driven primarily by a $241 million increase in solar cell sales [5][13] - Gross profit increased by 340% to $96.3 million in 2025, with gross profit margin expanding to 22.5% from 12.4% in 2024 [13][14] - Adjusted net income for 2025 was $52.2 million, compared to $6 million in 2024, while GAAP net income was $37.2 million, down from $40.5 million in the previous year [15][16] Business Line Data and Key Metrics Changes - The company successfully shipped 2.3 GW of solar cells from its Ethiopia facility to U.S. customers and 1.9 GW from its Vietnam facility to international markets [6][7] - The new 1 GW module facility in Houston began commercial operations in Q4 2025, with plans to scale up to 2 GW by 2026 [7][8] Market Data and Key Metrics Changes - The company is positioned to meet the accelerating demand in the U.S. solar market, with shipment guidance for 2026 set between 5.5 and 5.8 GW for solar cells and 1 to 1.3 GW for solar modules [10][11] - The operational focus for 2026 includes maximizing existing infrastructure and expanding domestic production capabilities [11][12] Company Strategy and Development Direction - TOYO aims to strengthen its position as a vertically integrated solution provider, focusing on high-efficiency, policy-compliant solar cell technology [5][9] - The acquisition of the BridgeSun brand is intended to streamline operations and enhance growth without diluting shareholder value [8][9] Management's Comments on Operating Environment and Future Outlook - Management highlighted the challenges faced in the solar industry but emphasized the company's ability to double revenue and improve margins, indicating a strong strategic position [10] - The company anticipates adjusted net income of approximately $90 million to $100 million for 2026, despite significant investments in R&D [12][17] Other Important Information - TOYO generated $133 million in cash flow from operations in 2025, with $92 million invested in capital expenditures across its facilities [17] - The company plans to report quarterly earnings starting in 2026, enhancing engagement with the investor community [27] Q&A Session Summary Question: Insights on gross margins with increased U.S. revenue share - Management indicated that they expect to maintain competitive margins as operations ramp up in Ethiopia and Houston [20][22] Question: Potential credits for Houston production capacity in 2026 - Management is cautious about providing guidance on credits but mentioned plans for pilot production of additional capacity in Houston [25][26] Question: Future earnings call frequency - Management confirmed plans to report quarterly earnings starting in 2026, enhancing communication with investors [27]

Financial Data and Key Metrics Changes - Prairie generated approximately $242 million in revenue for 2025, or $315 million when including Bayswater's assets, reflecting a nearly 3,000% increase in revenues year-over-year [10][11] - Adjusted EBITDA totaled approximately $156 million, with a pro forma contribution from Bayswater assets bringing it to about $220 million, slightly below the guidance of $240 million [11][8] - The net loss attributable to common stockholders was $60.9 million, or $1.35 per share, primarily due to non-cash expenses [10] Business Line Data and Key Metrics Changes - Total production for 2025 was approximately 6.75 million BOE, averaging 18,500 BOE per day, with an exit rate of about 28,000 net BOE per day [5][6] - Including Bayswater's first quarter production, the full year production would have been approximately 24,000 BOE per day, representing almost a 4x increase year-over-year [6] Market Data and Key Metrics Changes - Realized prices were $63.87 per barrel of oil, $17.93 per barrel of NGL, and $1.65 per Mcf of natural gas [10] - Prairie ended the year with 121.1 million BOE of proved reserves, with a PV-10 value of approximately $1.2 billion [13] Company Strategy and Development Direction - The company remains focused on disciplined capital allocation, operational execution, and delivering sustainable growth and long-term shareholder value [9][15] - Prairie plans to maintain a capital expenditure range of $200 million to $220 million for 2026, with expected average production of approximately 25,500 to 27,500 BOE per day [17] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's operational and financial success moving into 2026, highlighting a strong asset base and momentum exiting 2025 [17] - The leadership team is committed to enhancing financial strength and operational excellence while maintaining flexibility for accretive opportunities [15][17] Other Important Information - Prairie executed a series of bolt-on acquisitions throughout 2025, adding approximately 44,000 net acres and expanding its portfolio with high-quality proved inventory [6][5] - The company achieved a 0.0 safety record for the year, reflecting a perfect safety performance with no incidents [13] Q&A Session Summary Question: Can you provide more details on production expectations for the first quarter and throughout the year? - Management indicated that Q1 production is expected to average around 23,000 BOE per day due to shut-in production, with a gradual increase anticipated throughout the year [21][22] Question: What is the current performance of recent wells compared to prior wells? - Recent wells have shown varied performance, with Opal Coal Bank performing well, while Noble and Simpson wells faced challenges due to offset operators and equipment delays [25][27] Question: What are the current share count and status of preferred refinancing? - The share count has increased from the low sixties at year-end, with ongoing conversions from preferred shares, indicating good communication with preferred holders [30][29] Question: How will cash flow be prioritized in 2026? - The company aims to use free cash flow for debt reduction and potential acquisitions, maintaining a conservative approach to financial management [34][35] Question: Are there any anticipated constraints from midstream systems? - Management does not foresee any constraints on production plans through 2026 or 2027, having aligned development plans with midstream partners [37][38] Question: Will there be flexibility in CapEx guidance based on market conditions? - The company plans to maintain a focus on balance sheet robustness and operational efficiencies, with potential adjustments based on market conditions [40][41]

Purple Innovation (NasdaqGS:PRPL) Q4 2025 Earnings call March 31, 2026 08:30 AM ET Company ParticipantsAlessandra Jimenez - Senior Equity Research AssociateBrad Thomas - Associate Director of ResearchRobert DeMartini - CEOStacy Turnof - EVP of Strategic Situations and Investor RelationsTodd Vogensen - CFOConference Call ParticipantsBrian Nagel - Managing Director and Senior AnalystDan Silverstein - Equity Research AnalystMatt Koranda - Managing Director and Senior Research AnalystOperatorThank you for stand ...

Financial Data and Key Metrics Changes - In 2025, the company generated $255 million in total revenues, representing a 29% growth compared to 2024 [11] - Total assets under management (AUM) reached $50 billion at year-end, up 10% year-over-year [13] - Adjusted EBITDA increased 45% to approximately $35 million for the year [17] - The company reported a net loss of $155 million for the year, largely driven by non-cash non-recurring items [18] Business Line Data and Key Metrics Changes - The core revenue base remained anchored in nearly $200 million of predictable recurring management fees, which increased by 9% year-over-year [11][15] - The endowment and foundation business grew to more than $8 billion in AUM at year-end 2025 [8] - Incentive fees contributed significantly to revenue, with a $29 million contribution in the fourth quarter alone [14] Market Data and Key Metrics Changes - The company experienced strong demand from ultra-high net worth and institutional clients across U.S. and international businesses, adding nearly $4 billion in projected billable assets in 2025 [9] - The international business faced foreign exchange headwinds due to U.S. dollar depreciation, impacting growth [13] Company Strategy and Development Direction - The company aims to build a premier global wealth management platform focused on the ultra-high net worth segment [4] - A strategic assessment led to the exit of the non-core International Real Estate business, allowing for a simplified organizational structure [10] - The adoption of zero-based budgeting is expected to yield approximately $20 million in recurring annual gross savings by year-end 2026 [10] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's ability to deliver sustained growth and increased profitability over time, supported by a focused strategy and durable client relationships [19] - The company anticipates that 2026 will mark a turning point, with improved visibility of operating leverage and expense trends as initiatives take hold [18] Other Important Information - The company has formed a special committee to review strategic options to maximize long-term shareholder value, with no proposals received to date that encapsulate the business's long-term value [12] Q&A Session Summary Question: Could you provide more color on the decision to transition CEOs? - Management indicated that the transition was a thoughtful decision aimed at positioning the company for its next phase of growth while maintaining continuity in strategy [24] Question: Can you provide an update on the zero-based budgeting (ZBB)? - ZBB is expected to yield $20 million in savings over approximately nine quarters, with improvements in non-comp expenses and occupancy costs anticipated as contracts expire [47] Question: What is the status of Allianz's 13D filing? - Allianz has been a strategic partner, and any plans to increase engagement would require a filing, but there is currently no visibility into their intentions [43][44] Question: Can you discuss the merger arbitrage performance? - The merger arbitrage strategy performed well in 2025, generating an 11.3% return, which positively impacted management fees and incentive fees [35][36] Question: What is the outlook for capital and potential acquisitions? - The company does not foresee a need for funding for organic growth initiatives but is confident in its ability to raise capital for attractive inorganic opportunities if identified [51][53]

Solesence (NasdaqCM:SLSN) Q4 2025 Earnings call March 31, 2026 08:30 AM ET Company ParticipantsKevin Cureton - President and CEOLaura Riffner - CFOStefano Bolis - ShareholderTony Rubin - ShareholderWayne Ruin - ShareholderConference Call ParticipantsJames Liberman - AnalystOperatorGood day. Thank you for standing by. Welcome to the Solésence fourth quarter and full year 2025 conference call. Today's call is being recorded. During this call, management will make statements that include forward-looking statem ...